Advisory Boards

MphaR Our Services Advisory Boards
Our expert engagement solutions—ranging from in-person Advisory Boards to fully digital Virtual Advisory Boards and Steering Committees—enable scientific leaders to collaborate effectively anywhere in the world.With the MphaR Virtual Advisory Board Platform, we combine synchronous and asynchronous tools to deliver deeper insights, stronger participation, and efficient decision support.

Advisory Boards

Advisory Boards are a vital channel for gathering expert insights that strengthen medical strategy, scientific communication, and evidence generation. At MphaR, we design and execute highly effective Advisory Boards—both in-person and virtual—ensuring meaningful scientific exchange and high-quality outputs.

Our approach focuses on structured preparation, expert facilitation, and insightful reporting, enabling your team to gain actionable guidance from leading specialists across therapeutic areas.

What We Offer

Strategic Planning & Design

We work with your Medical Affairs team to shape the focus of the Advisory Board by:
  • Defining clear scientific and strategic objectives
  • Identifying relevant topics, gaps, and key questions
  • Selecting and inviting the right experts (KOLs, HCPs, multidisciplinary stakeholders)
  • Developing agendas that encourage rich, balanced discussion 

Expert Coordination & Logistics

MphaR manages all operational elements, ensuring a smooth and professional experience:
  • Contracting and honoraria coordination
  • Participant communication and reminders
  • Venue, travel, and virtual platform setup
  • Compliance alignment with internal and external guidelines

Scientific Support During the Meeting

Our team provides robust scientific and technical support throughout the session:
  • On-site or virtual meeting moderation
  • Real-time insights capture
  • Facilitation tools to encourage participation (polls, breakout rooms, digital boards)
  • Adherence to compliance standards during interactions Adherence to compliance standards during interactions

Insightful Post-Meeting Deliverables

We ensure all discussions are translated into clear, actionable outcomes:
  • High-quality meeting minutes
  • Executive summaries of key insights
  • Categorized recommendations aligned with strategic priorities
  • Optional AI-enhanced summaries via the MphaR digital platform
These outputs support decision-making across Medical Affairs, clinical development, and communication planning. 

Why Choose MphaR for Advisory Boards

End-to-end scientific, operational, and compliance support

  • Experience with global and regional expert groups
  • Structured methodology for maximizing expert engagement
  • Fast, high-quality insight reporting
  • Advanced virtual technology for modern advisory formats

What HCPs and Medical Affairs Experts Tell About Working with Us

We work closely with HCPs and Medical Affairs experts worldwide. Here’s what they share about partnering with MphaR

Trusted by Industry Leaders

Medical Affairs Trends: Blog, Digest and Podcasts

Stay informed on emerging Medical Affairs trends with expert blog articles, and twice-monthly editions of our Medical Affairs Digest and podcasts series.

TrendWatch: Medical Affairs

Explore concise articles covering the latest trends and innovations in Medical Affairs

Latest Article

Beyond the Search Bar: How AI Is Turning Literature Reviews Into Scientific Strategy for Medical Affairs

The article explains how artificial intelligence is transforming literature review in Medical Affairs from a manual, time-intensive activity into a faster, intelligence-driven process. As scientific publications, conference abstracts, and real-world evidence continue to expand, AI technologies such as natural language processing and machine learning enable continuous evidence monitoring, automated categorization, and rapid summarization of relevant research. By helping teams identify emerging trends, prioritize high-impact evidence, and detect important scientific signals, AI allows Medical Affairs professionals to focus more on interpretation, strategic planning, and evidence-based decision-making. While AI improves efficiency and scalability, human oversight remains essential to validate sources, assess context, and ensure scientific accuracy and integrity. Ultimately, AI-supported literature review enhances the ability of Medical Affairs teams to generate meaningful insights and respond proactively to an increasingly complex scientific landscape.

Same Company, Different Outcomes: Why AI Adoption in Medical Affairs Comes Down to the Team

The article explains how building digital confidence is becoming essential for successful AI adoption in Medical Affairs. While AI is increasingly being used for activities such as literature monitoring, insight generation, evidence planning, and stakeholder engagement, the greatest value comes not from technology alone but from teams that can use it effectively and responsibly. AI readiness varies across organizations, with teams progressing from awareness and experimentation to routine application and full strategic integration. By combining AI tools with strong scientific judgment, Medical Affairs professionals can improve efficiency, uncover meaningful insights, and support more informed decision-making. Successful adoption requires ongoing education, structured governance, critical evaluation of AI outputs, and a culture that encourages learning and responsible innovation. Ultimately, the future of Medical Affairs will be shaped not by AI replacing expertise, but by digitally confident professionals who can combine human judgment with machine intelligence to drive scientific and strategic impact.

From Gatekeeper to Game-Changer: The Digital Transformation of Medical Affairs Compliance

The article explains how artificial intelligence and digital technologies are transforming compliance within Medical Affairs, shifting it from a slow, manual review process into a streamlined, automated, and workflow-integrated function. As the volume of scientific content and regulatory complexity continues to increase, AI-powered compliance platforms enable rapid identification of risk language, verification of claims, and detection of inconsistencies at scale. By embedding governance directly into content creation workflows—through automated MLR review, real-time audit trails, and standardized approval processes—compliance evolves from a final checkpoint into a continuous, compliant-by-design capability. This transformation enhances speed, consistency, and transparency while maintaining high standards of scientific and regulatory integrity. Supported by digital literacy, workflow optimization, and strong governance frameworks, compliance becomes an enabler rather than a barrier to scientific communication. Despite challenges related to implementation, skills gaps, and regulatory expectations, the integration of AI positions Medical Affairs compliance as a strategic asset that accelerates decision-making, strengthens credibility, and supports scalable, high-quality scientific engagement.

Bi-monthly Newsletter: Medical Affairs Digest

Your bi-monthly overview of essential Medical Affairs updates and emerging industry signals

Latest Newsletter
Bi-Monthly podcasts: Medical Affairs Voices

Listen to expert conversations exploring current trends and future directions in Medical Affairs

Precision Medicine in Oncology: Transforming Cancer Diagnostics Using AI Tools

In this episode, we uncover how artificial intelligence is transforming oncology, marking a shift from standardizedtreatments to precision medicine tailored to each patient’s genetic and molecular profile. From AI-powered imaging and digital pathology to genomic analysis and liquid biopsies, technology is reshaping how cancer is detected, understood, and treated. Hear how these innovations are driving earlier diagnoses, improving treatment accuracy, and empowering clinicians with insights once thought impossible. We also explore the ethical and practical challenges of integrating AI into cancercare and what it means for patients and providers alike. Join us as we look ahead to a future where AI doesn’t replace the human touch—it amplifies it, bringing us closer to truly personalized oncology care.

Leveraging AI and NLP to Transform Medical Information Systems in Medical Affairs

In this episode, we explore how artificial intelligence and natural language processing are reshaping how Medical Affairs teams manage, interpret, and apply vast volumes of unstructured medical information. From scientific literature and safety reports to advisory board insights and field intelligence, NLP is turning free text into structured, actionable knowledge—helping teams move faster while maintaining scientific rigor. Discover how NLP is being applied across literature intelligence, medical information systems, pharmacovigilance, and stakeholder engagement, and why human oversight remains essential in regulated medical environments. We also examine the risks, ethical considerations, and governance frameworks needed to ensure accuracy, transparency, and compliance. Join us as we look ahead to the evolution from language processing to true language understanding—and what this shift means for the future of Medical Affairs as a strategic, insight-driven function.

From Data to Dialogue — Strengthening Patient-Centricity Through Virtual Advisory Boards

In this episode, we examine how Virtual Advisory Boards are revolutionizing patient engagement, turning static data into meaningful dialogue that shapes real-world decisions. As patient-centricity becomes a defining principle in modern pharma, digital platforms are creating space for authentic collaboration between patients, caregivers, and industry leaders. Discover how virtual formats remove barriers to participation, ensure inclusivity, and make continuous patient input a practical reality. We’ll explore how the MphaR Virtual Advisory Board platform enables companies to integrate patient insights into trial design, treatment strategies, and beyond. Tune in as we explore how the future of patient engagement is being built—one conversation at a time—through innovation, empathy, and dialogue that truly puts patients at the center of healthcare.

Follow MphaR on Social Media:

MphaR Our Services Advisory Boards

FAQs

Typically, 6-10 experts. We guide you on the optimal number based on the objectives.
We prepare KOL shortlists, profiles, justification, and compliance documentation.
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure